ArticleFungal biology and biotechnology2025
Indigenizing fungal biotechnology for planetary health: an opinion paper.
Article in Fungal biology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
New fungal biotechnologies are advancing applied and conservation mycology to support global regenerative outcomes for natural and human systems. Here, we propose the Applied and Conservation Mycology Framework to align fungal biotechnology and Indigenous Knowledge Systems in support of planetary health, "the health of human civilization and the state of the natural systems it depends on." The Kunming-Montreal Global Biodiversity Framework (KM-GBF) adopted at the 2022 United Nations Biodiversity Conference is humanity's best effort at reconciling the sustainable development of all societies and biodiversity loss while reaffirming the rights of Indigenous Peoples (IPs). Through Indigenous Data Sovereignty (IDSov) and Governance (IDGov), fungal biotechnologies could help address all 23 KM-GBF Targets. In this opinion paper, we apply Indigenous relational science and knowledge systems to explore how advancements in fungal biotechnology and digital technology enable Indigenous Peoples to develop, practice, and govern fungal biotechnologies for applied and conservation mycology. We focus on the Kara & Kichwa Nations, Indigenous Peoples of Ecuador, the Cultural Mountain of Andea, and the Cultural Rainforest of Amazonia. The ACMF centers on fungal biotechnological innovation by Indigenous Peoples and their participation in the global bioeconomy in the service of planetary health and all 23 KM-GBF Targets. We offer a starting point for envisioning future fungal technologies developed by Indigenous Peoples and in service of planetary health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.